The Association of the Prevalence of Depression in Type 2 Diabetes Mellitus with Visual-Related Quality of Life and Social Support
Xiaoxia Ding,Shisong Rong,Yu Wang,Dong Li,Liang Wen,Bo Zou,Dongxiao Zang,Kemi Feng,Yuanbo Liang,Fenghua Wang,Gang Zhai
DOI: https://doi.org/10.2147/DMSO.S343926
2022-02-22
Abstract:Xiaoxia Ding, 1 Shisong Rong, 2 Yu Wang, 1 Dong Li, 1 Liang Wen, 1 Bo Zou, 1 Dongxiao Zang, 1 Kemi Feng, 3 Yuanbo Liang, 3 Fenghua Wang, 4 Gang Zhai 1 1 Department of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China; 2 Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA, USA; 3 Department of Ophthalmology, the Affiliated Eye Hospital, School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China; 4 Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Science Key Laboratory, Beijing, People's Republic of China Correspondence: Gang Zhai, Fushun Eye Hospital, No. 1 Hupo Street, Xinfu District, Fushun, Liaoning, 113008, People's Republic of China, Email Aim: To report the prevalence of depression and its association with vision-related quality of life and social support in a type 2 diabetes mellitus (T2DM) population. Methods: Patients were recruited from a community-based study, Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT), conducted between July 2012 and May 2013 in China. Depression was assessed using the Centre for Epidemiological Studies Depression Scale (CES-D). Vision-related quality of life was evaluated using the Visual Function Questionnaire-25 (VFQ-25). Social support was captured with the Social Support Rating Scale (SSRS). Generalized linear models were used to estimate the individual and joint association of VFQ-25 composite score (VFQCS) and SSRS score (SSRSS) with depression. Results: A total of 1618 subjects (60.9% female) aged 61.69 ± 8.72 years in an urban district of Jiangjun Street, Fushun City, Liaoning province, Northeast China from July 2012 to May 2013 were recruited, of which, 23.36% (95% CI: 21.30– 25.42%) were identified with depression. Every 14.1 increase in VFQ-25 composite score decreased the risk of depression by half (OR = 0.5; 95% CI: 0.4– 0.6); with the elevation of 10.0 SSRS score the risk of depression decreased by 40% (OR = 0.6; 95% CI: 0.5– 0.7). Patients with the VFQCS less than 91.3 and SSRSS less than 38.0 had 5.9 times more risk of depression (OR = 5.9; 95% CI: 3.6– 9.7). Age (over 60 years) (OR = 0.6; 95% CI: 0.4– 0.9) and medical history of cardiovascular disease (OR = 1.7; 95% CI: 1.1– 2.5) were independently correlated with depression symptom. Conclusion: The prevalence of depression is high among patients with T2DM in urban district in northeast China. Vision-related quality of life and social support scores are significantly associated with depression. Measures should be taken to screen depressive symptoms in patients with type 2 diabetes patients. These patients need to be intervened with appropriate and effective treatment as early as possible. Meanwhile, behavioral health specialists should guide the patient to get and use social support sources effectively. Keywords: diabetic retinopathy, depression, quality of vision, Visual Function Questionnaire-25, Social Support Rating Scale The number of people with diabetes aged 20–79 years was predicted to rise to 642 million by 2040. 1 Diabetes has become a serious public health burden in China, 2 and its prevalence will likely increase due to population growth, aging, urbanization, and increasing number of obesity and physical inactivity. 1 Diabetes affects patient's visual and overall well-being in many ways. Diabetic retinopathy (DR), a leading cause of preventable blindness in working-aged people in the US, 3 has an age-standardized prevalence of 43.1%. 4 Diabetes also increases the risk of cataract, glaucoma, strabismus, and dry eye. Depression is also a public health problem in China. Many chronic or non-chronic systemic diseases are often considered to be associated with depression, such as diabetes, rheumatoid arthritis, and malignancies. 5–7 The risk of developing depression in diabetes population is two times higher than that in the diabetes-free population. 5 The occurrence of depression and diabetes leads to worse outcomes including reduced treatment adherence, which may lead to worse glycemic control, increased risk of complications, increased disability, reduced work productivity, increased treatment costs and reduced quality of life. 8–11 In addition, previous studies show that the coexistence of these two diseases can increase the risk of morbidity and mortality with major negative implications on the individuals, families and society. 12 International diabete -Abstract Truncated-